⚠ You're viewing a report from February 2023. Subscribe to get the latest →

FDA Enforcement — February 2023 Report

Automated analysis of 24 items from public government data sources. Updated daily.

Summary

24
Total items
20
High impact
4
Medium impact
0
Low impact

High-impact items this period

Dunagin Pharmaceuticals Inc. dba Massco Dental
Finished pharmaceuticals adulterated, CGMP violations
Why: Current good manufacturing practice non-compliance in pharma  ·  Feb 22  ·  Impact: HIGH
Capital Imports LLC
Foreign supplier verification program non-compliance
Why: Inadequate FSVP procedures for imported food products  ·  Feb 22  ·  Impact: HIGH
Primal Pet Foods, Inc.
Animal food prepared under insanitary conditions, adulterated
Why: CGMP violations in preparation, packing, or holding processes  ·  Feb 21  ·  Impact: HIGH
Gascó Industrial Corporation
CGMP violations in finished pharmaceutical manufacturing
Why: Adulteration or non-compliance with current Good Manufacturing Practices  ·  Feb 17  ·  Impact: HIGH
Arrow Reliance Inc.
Animal food prepared under insanitary conditions, adulterated
Why: CGMP violations in preparation, packing, or holding processes  ·  Feb 16  ·  Impact: HIGH
Frenda Corporation
Finished pharmaceuticals adulterated, CGMP violations
Why: Current good manufacturing practice non-compliance in pharma  ·  Feb 15  ·  Impact: HIGH
Midlab Incorporated
Finished pharmaceuticals adulterated, CGMP violations
Why: Current good manufacturing practice non-compliance in pharma  ·  Feb 15  ·  Impact: HIGH
Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil
Adulterated finished pharmaceutical products
Why: CGMP violations in foreign pharmaceutical manufacturing facility  ·  Feb 13  ·  Impact: HIGH
American Chinese Natural Herbs, Inc.
Dietary supplement CGMP violations, adulterated products
Why: Manufacturing, packaging, labeling deficiencies; product contamination  ·  Feb 10  ·  Impact: HIGH
Emmons Livestock
Unapproved new animal drug products distributed
Why: Marketing animal drugs without FDA approval  ·  Feb 10  ·  Impact: HIGH

Selected medium-impact items

K&D Vapors Inc
Tobacco control act violations; adulterated, misbranded products
Why: Non-compliance with smoking prevention and tobacco product regulations  ·  Feb 23  ·  Impact: MEDIUM
Dotmod, Inc.
Tobacco control act violations; adulterated, misbranded products
Why: Non-compliance with smoking prevention and tobacco product regulations  ·  Feb 17  ·  Impact: MEDIUM
Hastings Vapors LLC d/b/a Hastings Vapors
Tobacco control act violations; adulterated, misbranded products
Why: Non-compliance with smoking prevention and tobacco product regulations  ·  Feb 16  ·  Impact: MEDIUM
The Body Bean, LLC
Failure to register and list as drug manufacturer
Why: Non-compliance with mandatory FDA registration requirements  ·  Feb 06  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →